HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome.

Abstract
Omenn syndrome (OS) is an inherited disorder characterized by an absence of circulating B cells and an infiltration of the skin and the intestine by activated oligoclonal T lymphocytes, indicating that a profound defect in the lymphoid developmental program could be accountable for this condition. Inherited mutations in either the recombination activating genes RAG1 or RAG2, resulting in partial V(D)J recombinase activity, were shown to be responsible for OS. This study reports on the characterization of new RAG1/2 gene mutations in a series of 9 patients with OS. Given the occurrence of the same mutations in patients with T-B-severe combined immune deficiency or OS on 3 separate occasions, the proposal is made that an additional factor may be required in certain circumstances for the development of the Omenn phenotype. The nature of this factor is discussed.
AuthorsB Corneo, D Moshous, T Güngör, N Wulffraat, P Philippet, F L Le Deist, A Fischer, J P de Villartay
JournalBlood (Blood) Vol. 97 Issue 9 Pg. 2772-6 (May 01 2001) ISSN: 0006-4971 [Print] United States
PMID11313270 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA-Binding Proteins
  • Nuclear Proteins
  • RAG2 protein, human
  • V(D)J recombination activating protein 2
  • DNA Nucleotidyltransferases
  • VDJ Recombinases
Topics
  • DNA Nucleotidyltransferases (genetics, metabolism)
  • DNA-Binding Proteins
  • Female
  • Gene Expression Regulation, Enzymologic (immunology)
  • Genes, RAG-1
  • Humans
  • Infant
  • Male
  • Mutation
  • Nuclear Proteins
  • Severe Combined Immunodeficiency (enzymology, etiology, genetics)
  • Syndrome
  • VDJ Recombinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: